AVEO Oncology Announces Participation at Two Upcoming Virtual Investor Conferences

On November 10, 2021 AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, reported that members of its senior management team will participate in two upcoming virtual investor conferences (Press release, AVEO, NOV 10, 2021, View Source [SID1234595115]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel 2021 Healthcare Conference
Date: Monday, November 15
Time: 1:20 p.m. Eastern Time

4th Annual Evercore ISI Healthconx Conference
Date: Tuesday, November 30
Time: 12:35 p.m. Eastern Time

A webcast of the fireside chats, or the subsequent archived recordings can be accessed by visiting the Calendar of Events sub-section within the Investors section of the Company’s website at www.aveooncology.com. A replay of the webcast will be archived for 30 days following the presentation date.